GE HealthCare Technologies (GEHC) Cash from Operations Growth (3y) (2025 - 2026)
GE HealthCare Technologies (GEHC) Cash from Operations Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn | 0.50% |
| 10 | Steris | 21.54 Bn | 21.10 Bn | 697.10 Mn | 15.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.75% |
| Dec 31, 2025 | -0.41% |
| Sep 30, 2025 | -1.58% |
| Jun 30, 2025 | 90.81% |
| Mar 31, 2025 | -18.86% |